Patient and consumer representatives advising U.S. Food and Drug Administration (FDA) expert panels might actually be a Trojan horse for the pharmaceutical industry, a new study says.
If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.
If you want to read more Like this articles, you can visit our Science category.
